Indian health-tech startup Healthify is in talks to partner with more weight-loss drugmakers to offer health, nutrition and ...

The dispute centres on Novo Nordisk's Indian patents for semaglutide, which it markets globally as Ozempic and Wegovy for ...

Shares, though, were punished Monday after the drug maker said its blockbuster obesity treatment Wegovy failed to slow Alzheimer’s.

Target has expanded its protein and supplement sections as GLP-1 drugs like Ozempic reshape shopping habits, driving demand ...

The pharma giant said amycretin led to weight loss and diabetes reductions in both injection and pill versions.

The Food and Drug Administration is set to treat application under its priority program that seeks to accelerate the review ...

Women with polycystic ovary syndrome (PCOS) are increasingly using GLP-1 weight-loss drugs from Eli Lilly and Novo Nordisk, ...

Women with polycystic ovary syndrome are increasingly turning to blockbuster weight-loss drugs from Eli Lilly and Novo ...

The fresh plea follows a recent court order allowing Dr. Reddy’s Laboratories (DRL) to continue manufacturing and exporting ...

And one of them is pharmaceutical giant Pfizer ( PFE 0.04%). Now, with a major step along the path to entering this ...

Pharma companies need to move beyond the “weight loss Olympics” and focus on more durable treatments with fewer side effects, ...